Authors
Latest:
2020 Epilepsy Review: Much to Be Excited AboutDespite 2020 being a challenging year for those in medicine, the epilepsy therapeutic space featured a number of key steps forward.
Latest:
Hideki Garren, MD, PhD: Measuring MS Progression With Floodlight OpenThe smartphone application-led program, Floodlight Open, recently initiated in the US and Canada.
Latest:
Robert Califf, MD, Nominated by Biden Administration as Next FDA CommissionerHaving previously served as head of the organization during the Obama administration, Califf will replace current Acting Commissioner Janet Woodcock, MD.
Latest:
Davangere Devanand, MBBS, MD: Challenges in Symptom Management in Alzheimer DiseaseDavangere P. Devanand, MBBS, MD, discussed the possibility of neurologists prescribing low-dose lithium for patients with Alzheimer and symptoms of agitation.
Latest:
Aducanumab Reinvigorates the Fight Against Alzheimer DiseaseThe chief medical officer of ProMIS Neurosciences comments on how aducanumab will help propel innovation needed to drive the next generation of therapies for Alzheimer disease.
Latest:
Anli Liu, MD: Responsive Neurostimulation System for Cognition in EpilepsyLiu discussed this work and the findings of this proof-of-principle trial in memory in epilepsy.
Latest:
Novel and Emerging Targets in Multiple SclerosisExperts in neurology share their hopes for the future of multiple sclerosis treatment and discuss unmet needs and novel targets.
Latest:
Johan Verbraecken, MD, PhD: Challenges in Conducting Clinical Trials in OSAThe medical coordinator of the Multidisciplinary Sleep-Wake Disorders Center at Antwerp University Hospital spoke about how to address some of the issues faced in OSA treatment development.
Latest:
Zhibin Chen, PhD: Treatment Gap in Patients with Newly Diagnosed EpilepsyDespite accessibility to antiepileptic drugs in high-income settings, more than one-third of patients with newly diagnosed epilepsy were not treated or had delayed treatment.
Latest:
Shimrit Uliel-Sibony, MD: Can Patients Develop a CBD Tolerance?Uliel-Sibony discussed her and her colleagues' study of CBD, and its findings on when tolerance develops for which patient population.
Latest:
Trevor Resnick, MD: Treating Epilepsy By Blending Technology, Genetics, and PharmacologicsThe pediatric epileptologist at Nicklaus Children’s Hospital spoke about the future of epilepsy and shared which studies of the condition that he’s been keeping an eye on.
Latest:
Asher J. Albertson, MD, PhD: Getting Interventions to Stroke PatientsAlbertson discussed this facet of stroke care, and all the things being done outside just the clinic to help improve outcomes.
Latest:
Shift in Treatment Paradigm for Dravet Syndrome: Joseph Sullivan, MDThe director of the Pediatric Epilepsy Center at UCSF provided perspective on the advances in the treatment of Dravet syndrome, emerging research concepts in the field, and the influence of genetic testing. [WATCH TIME: 5 minutes]
Latest:
Spinal Muscular Atrophy and COVID-19: Guidance and Resources for ProvidersAdvocacy organization Cure SMA provides guidance for health care providers caring for patients with SMA during the ongoing COVID-19 pandemic.
Latest:
Optical Coherence Tomography Angiography Helps Differentiate MS and NMOSDAlthough existing research has shown structural differences between multiple sclerosis and neuromyelitis optica spectrum disorder in following optic neuritis, the new report also covers non–optic neuritis eyes.
Latest:
Exploring Genetic Variants and Global Challenges in Alzheimer Disease Research: Jeffery M. Vance, MD, PhDThe professor of human genetics at the University of Miami discussed the significance of various genetic factors in Alzheimer risk and highlighted ongoing research, therapeutic challenges as well as the need for global collaboration. [WATCH TIME: 10 minutes]
Latest:
Results from the Subgroup Analysis of BECOME Caregiver Survey: Robert Iannone, MD, MSCEThe executive vice president of Global Head of Research and Development at Jazz Pharmaceuticals, spoke on the results from the BECOME study presented at the 2022 AES Conference. [WATCH TIME: 6 minutes]
Latest:
Advice for Physicians and the Multiple Sclerosis CommunityThe panel shares final advice for the multiple sclerosis community.
Latest:
Mitchell Miglis, MD: A Bidirectional Link Between Autonomic Dysfunction, HypersomniasThe autonomic disorders and sleep medicine specialist at Stanford University spoke about the overlap of autonomic disorders in sleep medicine, an often underrepresented portion of the sleep medicine field.
Latest:
Tools and Resources for the Management of MSDrs Jeffrey Dunn and Regina Berkovich review available tools and resources for the care of patients with multiple sclerosis, focusing on specific symptoms.
Latest:
James W. Wheless, MD: Making Treatment Decisions in EpilepsyThe professor and chief of pediatric neurology at Le Bonheur Children’s Hospital and the University of Tennessee Health Science Center discussed the decision-making process for choosing interventions for patients with epilepsy, and how to keep patients adherent.
Latest:
Harald Hampel, MD, PhD, MA, MSc on Advancements and Challenges in the Alzheimer SpaceHampel looks to the future of the Alzheimer space and sees promise, especially since there’s transfertilization from other advanced science fields in medicine like oncology, diabetes research and rheumatology.
Latest:
The Frequency of Occurrence of Narcolepsy SymptomsDrs Thorpy, Dogan, Doghramji, and Kushida discuss the frequency of symptoms encountered in patients who are diagnosed with narcolepsy.
Latest:
What to Expect at MDA’s 2025 Clinical and Scientific Conference: Barry J. Byrne, MD, PhDThe chief medical advisor at the Muscular Dystrophy Association shared key highlights of what attendees can expect at the 2025 MDA Clinical and Scientific Conference. [WATCH TIME: 4 minutes]
